Language
English
عربي
Tiếng Việt
русский
français
español
日本語
한글
Deutsch
हिन्दी
简体中文
繁體中文
API
Home
How To Use
Language
English
عربي
Tiếng Việt
русский
français
español
日本語
한글
Deutsch
हिन्दी
简体中文
繁體中文
Home
Detail
@xevxeev: affordable leakproof tumbler reco #tumbler #leakprooftumbler
katana
Open In TikTok:
Region: PH
Tuesday 11 November 2025 13:22:31 GMT
112177
993
12
112
Music
Download
No Watermark .mp4 (
0.95MB
)
No Watermark(HD) .mp4 (
1.01MB
)
Watermark .mp4 (
0MB
)
Music .mp3
Comments
rena :
Color?
2025-11-12 15:37:32
0
KemDMshop :
wow
2026-07-02 23:40:09
0
Tagatugis wan o tare' :
naay lain color ?
2025-11-13 13:09:35
1
R৻ꪆ :
Omg leakproof na din 💯
2025-11-11 15:59:03
0
ky :
ang gandaaaa
2025-11-12 15:22:32
1
katana :
leakproof tumbler reco
2025-11-12 15:39:28
1
Isabella's Apparel :
so sleek 😍
2025-11-12 18:29:00
0
Tagatugis wan o tare' :
cute tumbler
2025-12-23 23:47:25
0
To see more videos from user @xevxeev, please go to the Tikwm homepage.
Other Videos
💎True aesthetics lie in the details. At DentalWorldTR, every smile is crafted like a work of art. 📍 With our team of experts in Hollywood Smile, implants, and zirconium, we bring you a radiant, confident smile. ✨ 📞+905050228448 #LuxurySmileMakeover #SmileTransformation #hollywoodsmileturkey #zirconiumcrowns #ZirconiumCrownsTurkey
Tổng hợp ảnh động cho ae nào cần #xuhuong #hottrend #xuhuongtiktok #livephoto
#Biscoitocut
#Tiktokrwanda # #tiktok burundi #
Politician Ro Khanna bought Moderna right before it jumped 170%, and he’s just bought this $20 pharma stock. But here’s what’s interesting: both trades happened through his family trust according to financial disclosures. The stock is Amneal Pharmaceuticals. While most of Wall Street is distracted by its recent FDA approval for a complex injection, they are completely missing its massive biosimilar expansion. Over 100 major biologic drugs are losing patent exclusivity over the coming decade, opening a staggering $300 billion market gap. While typical generic drug companies get crushed by brutal price wars, Amneal closed a $750 million buyout of Kashiv BioSciences to build a dominant empire in biosimilars. They’ve quietly posted consecutive years of growth and are targeting over $4 billion in revenue by the end of the decade. Now, the stock ran up over 100% this past year, and insiders have been selling into strength. Instead of blindly buying right now, I’m watching two specific items in the Form 10-Q filing and the Q3 earnings in October. I’ll post an update if the news is positive. Follow if you want to invest in what Ro Khanna is buying. Not financial advice. Always do your research before investing.
About
Robot
API
Legal
Privacy Policy